Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $123.9700 (-1.66%) ($122.6400 - $125.6700) on Wed. Apr. 27, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.39% (three month average) | RSI | 71 | Latest Price | $123.9700(-1.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND advances 4.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) XBI(56%) IWO(55%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.195% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) IBUY(-6%) GDXJ(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.195% (StdDev 2.39%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
5 Day Moving Average | $128.14(-3.25%) | 10 Day Moving Average | $127.21(-2.55%) | 20 Day Moving Average | $121.25(2.24%) | To recent high | -4.9% | To recent low | 44.5% | Market Cap | $1.992b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |